Processa Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCSA and other ETFs, options, and stocks.About PCSA
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica.
CEOGeorge K. Ng
CEOGeorge K. Ng
Employees10
Employees10
HeadquartersVero Beach, Florida
HeadquartersVero Beach, Florida
Founded2011
Founded2011
Employees10
Employees10
PCSA Key Statistics
Market cap7.52M
Market cap7.52M
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume123.73K
Average volume123.73K
High today$3.40
High today$3.40
Low today$3.22
Low today$3.22
Open price$3.22
Open price$3.22
Volume25.59K
Volume25.59K
52 Week high$22.80
52 Week high$22.80
52 Week low$2.74
52 Week low$2.74
Stock Snapshot
With a market cap of 7.52M, Processa Pharmaceuticals(PCSA) trades at $3.32. The stock has a price-to-earnings ratio of -0.09.
During the trading session on 2026-01-14, Processa Pharmaceuticals(PCSA) shares reached a daily high of $3.40 and a low of $3.22. At a current price of $3.32, the stock is +3.2% higher than the low and still -2.4% under the high.
Trading volume for Processa Pharmaceuticals(PCSA) stock has reached 25.59K, versus its average volume of 123.73K.
Over the past 52 weeks, Processa Pharmaceuticals(PCSA) stock has traded between a high of $22.80 and a low of $2.74.
Over the past 52 weeks, Processa Pharmaceuticals(PCSA) stock has traded between a high of $22.80 and a low of $2.74.
People also own
Based on the portfolios of people who own PCSA. This list is generated using Robinhood data, and it’s not a recommendation.